Home COVID-19 Covaxin/Covishield: When Should You Get The Second Dose Of Vaccine?

Covaxin/Covishield: When Should You Get The Second Dose Of Vaccine?

Covaxin/Covishield: When Should You Get The Second Dose Of Vaccine ?

Second Dose Of Covaxin/Covishield: Starting April 1, all people above the age of 45 will be eligible to get vaccinated against Covid-19 as the government looks to expand the nationwide inoculation drive. On Monday, the government had told states to increase the gap between the two doses of Covishield to 4-8 weeks since it will lead to enhanced protection.

There are two Covid-19 vaccines that are being used in India right now — Bharat Biotech’s Covaxin and Serum Institute of India’s Covishield.

When should I take the 2nd dose of vaccination?

It is recommended that the 2nd dose of Covaxin should be administered in the interval of 4 to 6 weeks from the date of 1st dose administration. For Covishield the recommended interval is 4 to 8 weeks. You may choose the date of 2nd dose vaccination at your convenience.

The Centre has also advised people to take the second dose of Covishield between six and eight weeks after the first and protection from the killer virus would be optimum during this period, however, a delay beyond the eighth week may leave the beneficiary vulnerable.


Bharat Biotech’s Covaxin will cost 600 a dose for state governments and 1,200 a dose for private hospitals, the company said today.

Meanwhile, the Serum Institute of India will sell Covishield at 400 a shot to state governments and 600 a shot to private hospitals.

Is it necessary to take 2nd dose of vaccination?

Yes. It is recommended that both doses of vaccine should be taken for realizing the full benefit of vaccination. Both doses must be of the same vaccine type.

What is the expected immediate and delayed side effects of this vaccine?

Covishield: Some mild symptoms may occur like injection site tenderness, injection site pain, headache, fatigue, myalgia, malaise, pyrexia, chills and arthralgia, nausea. Very rare events of demyelinating disorders have been reported following vaccination with this vaccine but without the causal relationship establishment.

Covaxin: Some mild symptoms AEFIs may occur like injection site pain, headache, fatigue, fever, body ache, abdominal pain, nausea and vomiting, dizziness-giddiness, tremor, sweating, cold, cough and injection site swelling. No other vaccine-related serious adverse effects have been reported.